Octave Bioscience

Octave Bioscience Inc. is a commercial-stage company based in Menlo Park, California. As a precision-medicine company, Octave focuses on developing innovative solutions for the management of Multiple Sclerosis and other neurodegenerative diseases. With a team of 88 employees, Octave has generated $50 million in revenue. Octave offers a comprehensive Precision Care Solution that empowers healthcare providers with tools to better manage complex neurodegenerative diseases. Their flagship product, the Octave MSDA Test, is a groundbreaking multivariate blood test that provides accurate and objective measurements of disease activity in Multiple Sclerosis patients. Beyond the test, the Octave Solution encompasses enhanced MRI analytics, protocols, and a clinical care program that connects patients with specialized nurse care partners. Octave's approach distinguishes itself by integrating multiple data sources, including biological and contextual information, to create a holistic patient profile. This integrated approach delivers longitudinal perspectives and population-level insights, addressing unmet needs throughout the healthcare ecosystem. To learn more about Octave Bioscience and their Precision Care Solution, visit their website at octavebio.com.